The pharmaceutical company said it will focus instead on a once-daily version of the pill, danuglipron, instead of starting a late-stage study of the other version.
Pharmacists are knocking themselves out to mitigate the impact of drug shortages for patients right now. Why are physicians giving them such a hard time?
